CYXONE AB SK-,75 Aktie - Unternehmensdaten & Kurse - SE0007815428 | MoneyPeak

CYXONE AB SK-,75

Share · SE0007815428 · A2AHCN (XSTO)

No Price

n/a

Share Float & Liquidity

Free Float 52,55 %

Shares Float 197,09 M

Shares Outstanding 375,06 M

Company Profile for CYXONE AB SK-,75 Share

Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.

Get up to date insights from finAgent about CYXONE AB SK-,75

Company Data

Name CYXONE AB SK-,75

Company Cyxone AB (publ)

Website https://www.cyxone.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2AHCN

ISIN SE0007815428

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Kjell G. Stenberg

Country Sweden

Currency SEK

Employees 0,0 T

Address Adelgatan 21, 221 22 Malmö

IPO Date 2016-06-07

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	CYXO.ST
Frankfurt	4CX.F

More Shares

Investors who hold CYXONE AB SK-,75 also have the following shares in their portfolio:

DZ BANK IS.A716 Bond

FRANK.LIB.KOREA ETF DLA ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025